Boston Scientific Corp (BSX) stock saw a modest uptick, ending the day at $95.95 which represents a slight increase of $3.96 or 4.30% from the prior close of $91.99. The stock opened at $96.68 and ...
Johnson & Johnson stock skidded Wednesday after the company temporarily paused sales of its pulsed field ablation system.
Marlborough-based Boston Scientific has entered into a definitive agreement to acquire California-based medical equipment ...
Boston Scientific Corporation (BSX), headquartered in Marlborough, Massachusetts, develops, manufactures, and markets medical ...
Patrick Wood, an analyst from Morgan Stanley, maintained the Buy rating on Boston Scientific (BSX – Research Report). The associated price ...
Bernstein raised the firm’s price target on Boston Scientific (BSX) to $110 from $100 and keeps an Outperform rating on the shares as part of a ...
The deal for Bolt, developer of an intravascular lithotripsy system to treat coronary and peripheral artery disease, ...
Boston Scientific (NYSE: BSX) announced today that it agreed to acquire intravascular lithotripsy (IVL) platform developer ...
Boston Scientific (BSX) reachead $91.99 at the closing of the latest trading day, reflecting a +0.77% change compared to its last close.
Boston Scientific closes the year at historic highs, with investors refusing to liquidate even at these levels. Check out why ...
Boston Scientific Corporation announced it has entered into a definitive agreement to acquire Bolt Medical, Inc., the ...
In the most recent trading session, Boston Scientific (BSX) closed at $91.29, indicating a +0.66% shift from the previous trading day.